Form4insider filings, from the source

SEC Form 4 · accession 0001126234-15-000049

NEWLINK GENETICS CORP · (NLNK)

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Nicholas N. Vahanian
Officer — President, Chief Medical Offic
Period of report
Mar 5, 2015
Accepted (ET)
Mar 9, 2015 · 6:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001126234

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2,F3,F4Mar 5, 2015S60,000$49.89D40,839D
Common StockF3,F4Mar 9, 2015M2,521$0.80A43,360D
Common StockF3,F4Mar 9, 2015M10,479$2.10A53,839D
Common StockF3,F4Mar 9, 2015S15,000$49.57D38,839D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F5$0.80Mar 9, 2015M2,521DJan 1, 2010Jan 20, 2019Common Stock2,5210D
Stock Option (Right to Buy)F5$2.10Mar 9, 2015M10,479DJun 1, 2008May 12, 2019Common Stock10,479264,895D

Explanation of responses